250 Participants Needed

ADELANTE for HIV

Recruiting at 1 trial location
JH
Overseen ByJulie H Levison, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Massachusetts General Hospital
Must be taking: Antiretrovirals
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It seems focused on a behavioral intervention rather than medication changes.

What data supports the effectiveness of the ADELANTE treatment for HIV?

Research shows that community health worker interventions, a key part of the ADELANTE treatment, are effective in improving health outcomes for people living with HIV by increasing retention in care and helping with viral suppression.12345

Is the ADELANTE intervention generally safe for humans?

The ADELANTE intervention, delivered by community health workers, has been used in various studies to support people living with HIV. While these studies focus on improving health outcomes, they do not report any specific safety concerns related to the intervention itself.36789

How is the ADELANTE treatment for HIV different from other treatments?

The ADELANTE treatment is unique because it involves community health workers (CHWs) delivering a problem-solving intervention to help people with HIV, focusing on increasing retention in care and improving viral suppression, especially in racial/ethnic minority communities. This approach is different from standard medical treatments as it emphasizes community-based support and counseling rather than just medication.28101112

What is the purpose of this trial?

The goal of this study is to test the effectiveness of ADELANTE on viral suppression among Latinos with HIV and viral non-suppression. Participants will receive ADELANTE (5-session, community health worker-delivered, problem-solving intervention) or enhanced care condition (ECC, 5 reminder phone calls). We will evaluate the overall effectiveness of ADELANTE compared with ECC on rates of viral suppression and emergency room visits and hospitalizations. Our hypothesis is that ADELANTE participants will achieve higher rates of viral suppression and will have lower rates of emergency room visits and hospitalizations compared with ECC at 12 months post-randomization.

Eligibility Criteria

This trial is for Latinos with HIV who are struggling to keep the virus under control. Participants will be randomly assigned to receive either a new intervention called ADELANTE, which includes five sessions with a community health worker, or an enhanced care condition involving five reminder phone calls.

Inclusion Criteria

Confirmed HIV infection by standard laboratory results
Medical record evidence with last viral load (VL) indicating viral non-suppression (HIV RNA ≥200 cpm) within 90 days of assessment of eligibility
Receiving HIV primary care at Jackson Memorial Hospital or Thomas Street at Quentin Mease Health Center/Harris Health System
See 2 more

Exclusion Criteria

I am unable to understand and make decisions about my treatment.
Currently participating in an HIV intervention study with ongoing follow-up
Plans to move out of the county in the next 6 months

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants receive 5 individualized problem-solving sessions delivered by a community health worker over 6 months, framed around a bi-lingual film about HIV

6 months
5 sessions (in-person or virtual)

Enhanced Care Condition

Participants receive 5 locator phone calls confirming contact information and routine HIV health promotion materials

6 months
5 phone calls

Follow-up

Participants are monitored for viral suppression, emergency room visits, and hospitalizations

12 months
Assessments at baseline, month-3, month-6, and month-12

Treatment Details

Interventions

  • ADELANTE
Trial Overview The study aims to see if ADELANTE can help participants better manage their HIV and achieve viral suppression compared to those receiving just reminder calls. The success of the program will be measured by checking rates of viral suppression and tracking emergency room visits and hospitalizations over a year.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: ADELANTEExperimental Treatment1 Intervention
Participants will receive 5, individualized problem solving sessions delivered by a community health worker over 6 months. The intervention content is framed around a bi-lingual film about HIV.
Group II: Enhanced Care ConditionActive Control1 Intervention
Participants in the enhanced care control group will receive 5 locator phone calls confirming contact information at the same interval as CHW sessions in the ADELANTE group. They will be offered routine HIV health promotion materials as is available in the clinic. If a participant requests support for navigation or case management, they will be encouraged to contact their HIV team

ADELANTE is already approved in United States for the following indications:

🇺🇸
Approved in United States as ADELANTE for:
  • Improving engagement in care for Latinos with HIV and viral non-suppression

Find a Clinic Near You

Who Is Running the Clinical Trial?

Massachusetts General Hospital

Lead Sponsor

Trials
3,066
Recruited
13,430,000+

Baylor College of Medicine

Collaborator

Trials
1,044
Recruited
6,031,000+

University of Miami

Collaborator

Trials
976
Recruited
423,000+

Findings from Research

Indigenous outreach workers have been effective in reducing HIV risk behaviors and promoting preventive actions among injection drug users (IDUs), contributing to a decrease in HIV seroincidence in various cities.
The study highlights the evolving role of outreach workers as case managers, emphasizing their importance in addressing the complex needs of IDUs and improving their health and living conditions through tailored support.
Stories of AIDS outreach and case management: context and activities.Rahimian, A., Pach, A.[2019]
Community health workers (CHWs) play a crucial role in improving care retention and viral suppression for people living with HIV, but their effectiveness is hindered by unclear roles, inadequate funding, and limited training opportunities.
Key factors for successful CHW integration include establishing standardized roles, fostering interorganizational networks, and providing comprehensive training in areas like trauma-informed care and cultural humility, which can enhance their impact on HIV care outcomes.
Using Implementation Science to Promote Integration and Sustainability of Community Health Workers in the HIV Workforce.Rajabiun, S., Killion, K., Lennon-Dearing, R., et al.[2023]
Community health worker (CHW) interventions show promise in improving psychosocial outcomes for people living with HIV, particularly in areas like quality of life and self-efficacy, based on a review of 14 randomized controlled trials.
However, these interventions have not been effective in reducing depressive symptoms or stigma related to HIV, indicating a need for future studies to expand their focus and incorporate measures of intervention fidelity.
Community health worker interventions to promote psychosocial outcomes among people living with HIV-A systematic review.Han, HR., Kim, K., Murphy, J., et al.[2019]

References

Stories of AIDS outreach and case management: context and activities. [2019]
Using Implementation Science to Promote Integration and Sustainability of Community Health Workers in the HIV Workforce. [2023]
Community health worker interventions to promote psychosocial outcomes among people living with HIV-A systematic review. [2019]
Community health workers as a cornerstone for integrating HIV and primary healthcare. [2022]
Client Satisfaction with Community Health Workers in HIV Care Teams. [2021]
Barriers and facilitators of rendering HIV services by community health workers in sub-Saharan Africa: a meta-synthesis protocol. [2021]
A three-year randomized community trial of community support workers in rural Ethiopia to promote retention in HIV care. [2023]
Using community health workers to improve clinical outcomes among people living with HIV: a randomized controlled trial. [2022]
Assessing the Influence of Community Health Worker Support on Early Antiretroviral Therapy Adherence, Anticipated Stigma, and Mental Health Among People Living with HIV in Tanzania. [2022]
A multi-site community randomized trial of community health workers to provide counseling and support for patients newly entering HIV care in rural Ethiopia: study design and baseline implementation. [2019]
Community-based health workers implementing universal access to HIV testing and treatment: lessons from South Africa and Zambia-HPTN 071 (PopART). [2022]
12.United Statespubmed.ncbi.nlm.nih.gov
Effectiveness of a community-based positive prevention intervention for people living with HIV who are not receiving antiretroviral treatment: a prospective cohort study. [2021]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security